bms204352 has been researched along with carbamates in 8 studies
Studies (bms204352) | Trials (bms204352) | Recent Studies (post-2010) (bms204352) | Studies (carbamates) | Trials (carbamates) | Recent Studies (post-2010) (carbamates) |
---|---|---|---|---|---|
49 | 1 | 12 | 13,717 | 985 | 4,744 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Christophersen, P; Jensen, BS; Jespersen, T; Olesen, SP; Schrøder, RL; Strøbaek, D | 1 |
Christensen, JK; Christophersen, P; Dupuis, DS; Jensen, BS; Jespersen, T; Olesen, SP; Schrøder, RL | 1 |
Ahring, PK; Brown, WD; Hartz, BP; Korsgaard, MP; Mirza, NR; Strøbaek, D | 1 |
Nielsen, AN; Redrobe, JP | 1 |
Hansen, HH; Kristensen, LV; Sandager-Nielsen, K | 1 |
Hansen, HH; Jensen, MM; Lange, SC; Mikkelsen, JD; Thomsen, MS | 1 |
Chadha, PS; Cockerill, GW; Davis, AJ; Greenwood, IA; Hansen, RS; Harhun, MI; Jepps, TA; Olesen, SP | 1 |
Chen, GD; Salvi, R; Sheppard, AM | 1 |
8 other study(ies) available for bms204352 and carbamates
Article | Year |
---|---|
KCNQ4 channel activation by BMS-204352 and retigabine.
Topics: Anticonvulsants; Carbamates; Cell Line; Dose-Response Relationship, Drug; Humans; Indoles; KCNQ Potassium Channels; Phenylenediamines; Potassium Channels; Potassium Channels, Voltage-Gated | 2001 |
Activation of KCNQ5 channels stably expressed in HEK293 cells by BMS-204352.
Topics: Anthracenes; Carbamates; Cell Line; Dose-Response Relationship, Drug; Gene Expression; Humans; Indoles; KCNQ Potassium Channels; Membrane Potentials; Phenylenediamines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Pyridines | 2002 |
Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels.
Topics: Algorithms; Animals; Anti-Anxiety Agents; Anxiety; Ataxia; Behavior, Animal; Carbamates; Cell Line; Dose-Response Relationship, Drug; Emotions; Exploratory Behavior; Female; Hand Strength; Indoles; KCNQ Potassium Channels; KCNQ1 Potassium Channel; Male; Membrane Potentials; Mice; Neurons; Oocytes; Patch-Clamp Techniques; Phenylenediamines; Potassium Channels, Voltage-Gated; Rats; Rats, Wistar; Receptors, GABA-A; RNA, Complementary; Stereoisomerism; Xenopus laevis | 2005 |
Effects of neuronal Kv7 potassium channel activators on hyperactivity in a rodent model of mania.
Topics: Amphetamine; Animals; Anticonvulsants; Antimanic Agents; Benzamides; Bipolar Disorder; Carbamates; Central Nervous System Stimulants; Chlordiazepoxide; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Hyperkinesis; Indoles; Injections, Intraperitoneal; KCNQ Potassium Channels; Lamotrigine; Lithium Compounds; Male; Mice; Mice, Inbred C57BL; Motor Activity; Phenylenediamines; Pyridines; Triazines | 2009 |
Kv7 (KCNQ) channel openers induce hypothermia in the mouse.
Topics: Animals; Anthracenes; Anticonvulsants; Benzamides; Body Temperature Regulation; Carbamates; Female; Hypothermia; Indoles; KCNQ Potassium Channels; Mice; Phenylenediamines; Protein Isoforms; Pyridines | 2011 |
The pharmacological effect of positive KCNQ (Kv7) modulators on dopamine release from striatal slices.
Topics: Animals; Anthracenes; Anticonvulsants; Benzamides; Carbamates; Dopamine; Dopamine Antagonists; In Vitro Techniques; Indoles; Inhibitory Concentration 50; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Male; Mesencephalon; Neostriatum; Neurons; Nonlinear Dynamics; Phenylenediamines; Potassium Channel Blockers; Potassium Chloride; Pyridines; Rats; Rats, Wistar; Regression Analysis | 2011 |
Downregulation of Kv7.4 channel activity in primary and secondary hypertension.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Blood Pressure; Carbamates; Down-Regulation; Hypertension; In Vitro Techniques; Indoles; KCNQ Potassium Channels; Male; Membrane Potentials; Mesenteric Arteries; Mice; Phenylenediamines; Rats; Rats, Inbred SHR; Rats, Wistar; Vasoconstrictor Agents | 2011 |
Potassium ion channel openers, Maxipost and Retigabine, protect against peripheral salicylate ototoxicity in rats.
Topics: Acoustic Stimulation; Animals; Carbamates; Cochlea; Cochlear Microphonic Potentials; Cytoprotection; Disease Models, Animal; Hearing Loss, Sensorineural; Indoles; KCNQ Potassium Channels; Large-Conductance Calcium-Activated Potassium Channels; Male; Otoacoustic Emissions, Spontaneous; Phenylenediamines; Potassium Channels; Rats, Sprague-Dawley; Sodium Salicylate; Tinnitus | 2015 |